Search Results for: Brain metastasis

October 22, 2024October 22, 2024

Quality of life after stereotactic radiosurgery for brain metastasis: an assessment from a prospective national registry.

Melanoma Literature

Publication date: Oct 21, 2024 Stereotactic radiosurgery (SRS) is frequently used in the management of brain metastasis patients. However, there is an urgent need to evaluate post-treatment outcomes and quality ... Read more

October 22, 2024October 22, 2024

Quality of life after stereotactic radiosurgery for brain metastasis: an assessment from a prospective national registry.

Melanoma Literature

October 22, 2024October 22, 2024

Quality of life after stereotactic radiosurgery for brain metastasis: an assessment from a prospective national registry.

Melanoma Literature

September 24, 2024September 24, 2024

Relatlimab/Nivolumab in Melanoma Improves Brain Metastasis–Free Survival

Melanoma News

Publication date: Sep 24, 2024 Adrenal insufficiency was 5. 4% ; pneumonitis was 3. 9% compared with 1. 9% with nivolumab, and grade 3/4 was 0. 6% in ... Read more

September 12, 2024September 12, 2024

Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery.

Melanoma Literature

Publication date: Sep 11, 2024 Stereotactic radiotherapy (SRT) is an established treatment for melanoma brain metastases (MBM). Recent evidence suggests that perilesional edema volume (PEV) might compromise the delivery and ... Read more

December 4, 2024December 4, 2024

A Multicenter, Phase II Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases

Melanoma News

Publication date: Nov 27, 2024 This is a multicenter, phase II trial of relatlimab (rela), nivolumab (nivo), and ipilimumab (ipi) in patients with asymptomatic and symptomatic melanoma brain metastases. Concepts ... Read more

November 29, 2024November 29, 2024

Metastatic Malignant Melanoma of Brain: A Rare Case Report.

Melanoma Literature

Publication date: Dec 01, 2024 Malignant melanoma is third most common cause of brain metastasis after lung and breast cancer. Most patients with brain metastases from malignant melanoma are diagnosed ... Read more

November 15, 2024November 15, 2024

T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vessels.

Melanoma Literature

Publication date: Nov 12, 2024 To improve immunotherapy for brain tumors, it is important to determine the principal intracranial site of T cell recruitment from the bloodstream and their intracranial ... Read more

November 15, 2024November 15, 2024

T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vessels.

Melanoma Literature

November 15, 2024November 15, 2024

T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vessels.

Melanoma Literature